Literature DB >> 9865869

Drugs causing fixed eruptions: a study of 450 cases.

A Mahboob1, T S Haroon.   

Abstract

BACKGROUND: Drug eruptions are among the most common cutaneous disorders encountered by the dermatologist. Some drug eruptions, although trivial, may cause cosmetic embarrassment and fixed drug eruption (FDE) is one of them. The diagnostic hallmark is its recurrence at previously affected sites.
OBJECTIVE: We evaluated 450 FDE patients to determine the causative drugs.
RESULTS: The ratio of men to women was 1:1.1. The main presentation of FDE was circular hyperpigmented lesion. Less commonly FDE presented as: nonpigmenting erythema, urticaria, dermatitis, periorbital or generalized hypermelanosis. Occasionally FDE mimicked lichen planus, erythema multiforme, Stevens-Johnson syndrome, paronychia, cheilitis, psoriasis, housewife's dermatitis, melasma, lichen planus actinicus, discoid lupus erythematosus, erythema annulare centrifugum, pemphigus vulgaris, chilblains, pityriasis rosea and vulval or perianal hypermelanosis. Cotrimoxazole was the most common cause of FDE. Other drugs incriminated were tetracycline, metamizole, phenylbutazone, paracetamol, acetylsalicylic acid, mefenamic acid, metronidazole, tinidazole, chlormezanone, amoxycillin, ampicillin, erythromycin, belladonna, griseofulvin, phenobarbitone, diclofenac sodium, indomethacin, ibuprofen, diflunisal, pyrantel pamoate, clindamycin, allopurinol, orphenadrine, and albendazole.
CONCLUSIONS: Cotrimoxazole was the most common cause of FDE, whereas FDE with diclofenac sodium, pyrantel pamoate, clindamycin, and albendazole were reported for the first time. FDE may have multiform presentations.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9865869     DOI: 10.1046/j.1365-4362.1998.00451.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  24 in total

1.  Bullous fixed drug eruption to ciprofloxacin: a case report.

Authors:  Sonia Pramod Jain; Pramod Ajit Jain
Journal:  J Clin Diagn Res       Date:  2013-04-01

2.  Fixed Drug Eruption due to Fluconazole: Not so uncommon Now-a-days.

Authors:  Ranjita Santra; Sushobhan Pramanik; Patralekha Raychaudhuri
Journal:  J Clin Diagn Res       Date:  2014-11-20

3.  Fixed drug eruption associated with aspirin.

Authors:  Menfil Orellana-Barrios; Rita Medrano Juarez; Nachiket J Patel
Journal:  BMJ Case Rep       Date:  2018-03-17

Review 4.  Road Less Traveled: Drug Hypersensitivity to Fluoroquinolones, Vancomycin, Tetracyclines, and Macrolides.

Authors:  Linda J Zhu; Anne Y Liu; Priscilla H Wong; Anna Chen Arroyo
Journal:  Clin Rev Allergy Immunol       Date:  2022-01-29       Impact factor: 10.817

5.  HLA-B*51:01 is strongly associated with clindamycin-related cutaneous adverse drug reactions.

Authors:  Y Yang; S Chen; F Yang; L Zhang; G Alterovitz; H Zhu; J Xuan; X Yang; H Luo; J Mu; L He; X Luo; Q Xing
Journal:  Pharmacogenomics J       Date:  2016-08-16       Impact factor: 3.550

6.  Fixed drug eruption resulting from fluconazole use: a case report.

Authors:  Mahkam Tavallaee; Mahnaz Mahmoudi Rad
Journal:  J Med Case Rep       Date:  2009-07-06

Review 7.  [Urological dermatosis].

Authors:  J Kranz; P Anheuser; H Lichtenstein; J Steffens
Journal:  Urologe A       Date:  2013-10       Impact factor: 0.639

8.  Clinical Management of Nonsteroidal Anti-inflammatory Drug Hypersensitivity.

Authors:  Mario Sánchez-Borges
Journal:  World Allergy Organ J       Date:  2008-02       Impact factor: 4.084

9.  Cutaneous adverse drug reactions in a tertiary care teaching hospital: A North Indian perspective.

Authors:  Ruchika Nandha; Anita Gupta; Arif Hashmi
Journal:  Int J Appl Basic Med Res       Date:  2011-01

10.  A case of allopurinol-induced fixed drug eruption confirmed with a lymphocyte transformation test.

Authors:  Min-Hye Kim; Eun-Jin Shim; Jae-Woo Jung; Seong-Wook Sohn; Hye-Ryun Kang
Journal:  Allergy Asthma Immunol Res       Date:  2012-03-29       Impact factor: 5.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.